GlassScriptPhysician profile
Ryan Daniel Bangart
NPI 1104342781
$4,596.84
in general payments reported to CMS, 2019-2025
24 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,401 · 2021: $1,438 · 2022: $701 · 2023: $381 · 2024: $237 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,299.73 | 2020-2022 | |
| Impactortho, INC. | $1,215.36 | 2021 | |
| Stryker Corporation | $410.73 | 2021-2025 | 7 X 23mm Citrelock Implant, Valor, Ortholoc 2 Lapifuse |
| Djo, LLC | $341.45 | 2020-2024 | Cmf |
| Nevro Corp. | $282.77 | 2022-2024 | Senza |
| Smith+Nephew, INC. | $149.47 | 2020-2025 | Grafix Pl, Collagenase Santyl |
| Orthofix Medical, INC. | $131.52 | 2022-2025 | Physio-Stim, Spinal-Stim |
| Integra Lifesciences Corporation | $101.64 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Angiodynamics, INC. | $101.24 | 2024-2025 | Venacure 1470 Pro |
| Abbvie INC. | $79.34 | 2025 | |
| Surgenex LLC | $66.91 | 2025 | Renograft, Pellograft, Surmatrix |
| Aap Implants INC | $64.24 | 2022 | |
| Melinta Therapeutics, LLC | $59.70 | 2020-2025 | Orbactiv, Kimyrsa |
| Zimmer Biomet Holdings, INC. | $52.26 | 2022 | |
| Treace Medical Concepts, INC. | $39.62 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $36.36 | 2024 | |
| Horizon Therapeutics Plc | $35.36 | 2021-2023 | Krystexxa |
| Amgen INC. | $32.79 | 2024-2025 | Krystexxa |
| Abbott Laboratories | $21.94 | 2025 | Proclaim |
| Nalu Medical, INC. | $20.65 | 2024 | Nalu Neurostimulation System |
| Bioventus LLC | $14.55 | 2025 | Exogen Ultrasound Bone Healing System |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.54 | 2025 | Jublia |
| Advanced Oxygen Therapy INC. | $12.96 | 2023 | Topical Oxygen Chamber For Extremities |
| Biotissue Holdings INC. | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bangart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.